A similar repression mechanism of interference was observed in prostate cancer cells, where Yu et al. found that ERG disrupts androgen receptor (AR) signalling by binding to and repressing AR downstream targets at gene-specific loci [119]. This evidence concerns the gene AR and prostate carcinoma.